Consilient Health’s Ian Sampson on the importance of traditional sales skills in an evolving...

  More than ever, we are adopting new and innovative ways to communicate, and pharma is no different. Whilst traditional sales skills are just as...

eDetailing: Where are we in 2018?

Words by Dr Andrée Bates Detailing remains a core part of any pharmaceutical company’s sales approach and has become a large part of their promotional...

How can pharma harness the power of data to inform its scientific communications strategy?

Words by Simon Mason Navigating the fast-changing healthcare data landscape is becoming increasingly challenging for pharma, owing to issues such as the rapid growth of...

Foreseeable future: MSD’s focus on emerging talent

    Adelina Ismail Role: Graduate Brand and Customer Manager, Vaccines & Women’s Health Degree: BSc Marketing Management (Hons), Lancaster University 2-year graduate scheme: First year as a junior brand...

Gaining access: For products to commercially succeed it’s about what and who you know

Words by Andreas Knight   Many consider market access as a new component of commercial pharma, but in reality it has always been around in one...

2018: A pivotal year for outsourcing for Ashfield

Managing Director of Ashfield Commercial and Clinical UK, Colin Watson, talks about meeting changing industry demands, new innovations for a new year and why...

Trailblazing Cambridge pharmaceutical supplier, Qdem, aims to follow its stellar 2017 with an outstanding...

Leaders of the pack Trailblazing Cambridge pharmaceutical supplier, Qdem, aims to follow its stellar 2017 with an outstanding 2018, all while delivering quality and value...

Closed loop – the DNA of pharma marketing by Kieran Bourke

  When planning a marketing strategy, pharmaceutical companies should consider adopting an integrated approach to make the most of the data they collect through website...

Into the 21st century: Inicio Consulting’s modern and panoramic approach means all bases are...

Unique Inicio is a niche go-to, multi-disciplinary agency that fuses strategic and commercial acumen with creative and analytical thinking. Our focus is on enhancing operational...

Latest articles

Investigational therapy has potential to become first oral GLP-1 receptor agonist for those living with type 2 diabetes

Novo Nordisk presents oral semaglitude data at ENDO

Oral semaglutide 7 mg and 14 mg doses showed superior reductions in blood sugar and weight compared to sitagliptin at 26 weeks in data...
Pf Award Winners

Pf Award Winners on the positive patient outcomes that come from working together

The winners of the Joint Working Pf Award 2018, Senior Coloplast Care Nurse Ruth Christer and NHS Partnership Manager, Coloplast, Jonathan Walker, on the...
Brain scan image: Detecting and managing atrial fibrillation

Detecting and managing atrial fibrillation

The ‘Podiatry and Atrial Fibrillation – Save a life, stop a stroke’ webinar was created to improve the detection and management of atrial fibrillation,...

Popular articles

Brain scan image: Detecting and managing atrial fibrillation

Detecting and managing atrial fibrillation

The ‘Podiatry and Atrial Fibrillation – Save a life, stop a stroke’ webinar was created to improve the detection and management of atrial fibrillation,...
Samsung Bioepis Announces Three-year Follow-up Data for Biosimilar ONTRUZANT® (trastuzumab) in Early or Locally Advanced HER2-positive Breast Cancer

Samsung Bioepis announces three-year follow-up data for biosimilar ONTRUZANT® (trastuzumab)

Samsung Bioepis announces three-year follow-up data for biosimilar ONTRUZANT® (trastuzumab) in early or locally advanced HER2-positive breast cancer. Samsung Bioepis has announced the findings of...
The future of genomics

The future of genomics and precision medicine

How is the use of genomics data enhancing our medical understanding and what does this mean for the future of precision medicine? Genomics is one of...
Investigational therapy has potential to become first oral GLP-1 receptor agonist for those living with type 2 diabetes

Novo Nordisk presents oral semaglitude data at ENDO

Oral semaglutide 7 mg and 14 mg doses showed superior reductions in blood sugar and weight compared to sitagliptin at 26 weeks in data...
Image of graduates: skills shortage in life sciences

Addressing the skills shortage in life sciences

How can collaboration help to fill the skills shortage gap to ensure that the UK can compete in the global future of life sciences? The...